Updated Jul 16, 2026
Cavanagh Bethany J is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $406K.
Bethany J. Cavanagh is the Senior Vice President of Finance and Treasurer at Beam Therapeutics Inc., a biotechnology company focused on precision genetic medicines. She has been involved in the company's financial operations and strategic planning.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-06 | BEAM | Beam Therapeutics Inc. | S — Open-market sale [10b5-1] | 3.2K | $24.58 | $80K |
| 2026-04-02 | BEAM | Beam Therapeutics Inc. | A — Grant or award | 20.0K | $0.00 | |
| 2026-01-26 | BEAM | Beam Therapeutics Inc. | S — Open-market sale [10b5-1] | 6.2K | $35.00 | $217K |
| 2026-01-21 | BEAM | Beam Therapeutics Inc. | S — Open-market sale [10b5-1] | 3.0K | $30.12 | $91K |
| 2025-10-01 | BEAM | Beam Therapeutics Inc. | S — Open-market sale | 467 | $24.53 | $11K |
| 2024-10-02 | BEAM | Beam Therapeutics Inc. | S — Open-market sale [10b5-1] | 289 | $23.48 | $7K |
| 2024-10-02 | BEAM | Beam Therapeutics Inc. | A — Grant or award [10b5-1] | 2.5K | $0.00 |
Bethany J. Cavanagh is the Senior Vice President of Finance and Treasurer at Beam Therapeutics Inc., a biotechnology company focused on precision genetic medicines. She has been involved in the company's financial operations and strategic planning.…
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($406K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Cavanagh Bethany J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.